BioSpace News Archive

According to the report, the global testosterone replacement therapy market was valued at US$ 1,613.7Mn in 2018 and is anticipated to expand at a CAGR of 4.4% from 2019 to 2030.

American Regent, Inc. is pleased to announce the launch of Selenious Acid Injection, USP in a new concentration and vial size.

InSitu Biologics, Inc. will share the latest investigational work on its hydrogel-lipid-microparticle matrix at the upcoming 47th Annual Regional and Acute Pain Medicine Meeting of the American Society of Regional Anesthesia in April 2022.

Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announced financial results for the full year 2021 and provided corporate updates.

Shanghai Zhimeng Biopharma, Inc. (“Zhimeng”), announced dosing of the first participant in the US Phase I study of its novel TLR8 agonist (CB06), which is being developed for the treatment of chronic hepatitis B virus infection.

The global microfluidics market size is estimated to worth around USD 62 billion by 2030 and expanding growth at a CAGR of 16.5% during the forecast period 2021 to 2030.

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd. focused on development of oncology, immunology, and critical care therapies, announced today the U.S. launch of CAMCEVI™ (leuprolide) 42mg injection emulsion for the treatment of advanced prostate cancer in adults.

Precedence Research Predicts, the joint pain injections market size is estimated to reach over US$ 7.08 billion by 2029 and expanding growth at a CAGR of 6.9% from 2021 to 2030.

The global interventional cardiology devices market is estimated to grow at a CAGR of 9.4% from 2021 to 2030 and to reach valuation US$ 46.72 billion by 2030.

The global drug and gene delivery devices market size is expected to hit USD 815 billion by 2030 from at USD 410 billion in 2021 and is expanding growth at a noteworthy CAGR of 7.2% from 2022 to 2030.